Sanofi Manufacturing Facility Sold for $33M
A Northborough life science facility leased to Sanofi Genzyme has been acquired by a joint venture of Wheelock Street Capital and Camber Development for $33 million.
Cambridge Crossing Gets $434M in Financing
Developer DivcoWest has received $433.8 million in construction financing for a pair of new buildings at Cambridge Crossing, including a 479,000-square-foot speculative office, lab and retail building on parcel EF.
Luminati Fills Up Cambridge Crossing Retail Building
A microdistillery and craft beer taproom has signed on as the final retail tenant at The Shed, the retail building opening next year at the 2.1 million-square-foot Cambridge Crossing development.
Sanofi Genzyme Sells Property to Life Science Developer for $20.5M
One of Greater Boston’s largest life science developers has made its second acquisition in Framingham with the $20.5 million acquisition of a 153,000-square-foot office and lab complex.
Shire Opening Research Center In Kendall Square
Irish pharmaceutical company Shire plc has leased 343,000 square feet at 500 Kendall St. in Cambridge for a new rare disease research hub.
Sanofi Genzyme Signs Lease For 47 Percent Expansion
Sanofi Genzyme, in collaboration with Ferris...
